PNTG — what changed in the latest 10-Q

Text added vs the prior filing · source: 10-Q · 2026-08-05

• Acquisitions. During the six months ended June 30, 2026, we expanded our operations with the addition of six senior living communities. A subsidiary of the Company entered into a separate operations transfer agreement with the prior operator of each acquired operation as part of each transaction.

• On July 30, 2026, CMS issued the Calendar Year (“CY”) 2027 Hospice Wage Index and Payment Rate Update proposed rule (“Hospice Payment Final Rule”). The Hospice Payment Final Rule’s net payment update percentage is 2.3%, which is an estimated increase of $755 million in payments from fiscal year 2026…

• The Hospice Payment Final Rule makes a technical change extending a hospice’s ability to use telehealth to conduct encounters that otherwise have to be conducted face-to-face through December 31, 2027, to align with the Consolidated Appropriations Act of 2026. Further, CMS has made the hospice elect…

• Effective May 13, 2026, CMS announced a six-month, nationwide moratorium on new Medicare enrollment applications for hospice providers and home health agencies (“HHA”); this applies to all initial Medicare enrollment applications and to certain changes in majority ownership of existing enrolled prov…

• On July 1, 2026, CMS published the CY 2027 Home Health Prospective Payment System proposed rule (“HHA Payment Proposed Rule”). The HHA Payment Proposed Rule includes several changes that, if finalized, could materially impact our home health offerings. Under the HHA Payment Proposed Rule, CMS propos…

Text removed vs the prior filing · source: 10-Q · 2026-05-06

• We experienced improvement in senior living revenue per occupied unit and occupancy during the three months ended March 31, 2026, compared to the same period in 2025. Despite year-over-year gains in revenue per occupied unit and occupancy, competition and inflation will continue to influence revenue…

• On February 3, 2026, the Consolidated Appropriations Act of 2026 (“CAA 2026”) was passed, which further extended government funding through September 30, 2026. Of specific importance to our businesses are:

• •Telehealth Waivers: Since the COVID-19 pandemic, Congress has temporarily waived restrictions so Medicare beneficiaries can access telehealth services at home and outside of rural areas. Medicare recipients can now continue using telehealth under these relaxed rules, regardless of location. The wai…

• ◦Lifting geographic limitations for medical telehealth services, allowing them to be provided nationwide, including in a person’s home such as an assisted living residence.

• ◦Delaying the Medicare requirement for in-person visits for mental health services provided through telehealth or audio-only telecommunications technology.

Text added vs the prior filing · source: 10-Q · 2026-08-05

• Under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange…

Text removed vs the prior filing · source: 10-Q · 2026-05-06

• Under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange…

• the period covered by this Quarterly Report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that these disclosure controls and procedures were effective to provide reasonable assurance that information we are required to disclose in reports that we f…

Text added vs the prior filing · source: 10-Q · 2026-08-05

• The Increasing Use of Artificial Intelligence Creates or Increases Regulatory and Business Risks That May Have a Material Impact on Our Results.

• We are increasingly incorporating artificial intelligence ("AI") and machine learning technologies into certain aspects of our operations. AI is also embedded in or utilized by third-party systems and vendor products on which we rely, in ways that may or may not be apparent. The inherent complexity …

• AI models may produce inaccurate, incomplete, or biased outputs due to limitations in data quality, biased training data, flawed algorithms, or changing data patterns. If AI-supported processes result in errors affecting clinical decision-making, patient care, administrative operations, or other asp…

• The legal and regulatory landscape governing AI in healthcare is rapidly evolving at the federal, state, and international levels. Changes in the laws or regulations, or uncertainty regarding their interpretation and enforcement, may increase our compliance costs, require modifications to our operat…

• In addition, our ability to compete effectively may depend in part on our ability to develop, adopt, and deploy AI technologies in a timely and cost-effective manner. If we are unable to do so, or if our competitors or new market entrants deploy AI more effectively, our competitive position could be…

Text removed vs the prior filing · source: 10-Q · 2026-05-06

• The Increasing Use of Artificial Intelligence Creates or Increases Regulatory and Business Risks That May Have a Material Impact on Our Results. The use of artificial intelligence (“AI”) in technology is rapidly expanding. AI is embedded in or utilized by systems in ways that may or may not be appar…